MICHIGAN MEDICINE ADVANCED GENITOURINARY MALIGNANCIES SYMPOSIUM 2025
Course Includes: 18 videos, 18 audios, 18 subtitle files (VTT), and 19 PDFs (Total Size: 5.16 GB)
Target Audience: Physicians (Medical Oncologists, Urologists, Radiation Oncologists, Internists)
Course Overview:
Join us for a one-day, intensive symposium dedicated to the comprehensive management of genitourinary malignancies, such as prostate, bladder, and kidney cancers. Hosted by the NCI-designated Rogel Cancer Center, this course emphasizes a transdisciplinary approach to reducing cancer burden and advancing health equity. It is an essential update for clinicians, bridging the gap between cutting-edge research—like novel biomarkers and cellular therapies—and standard clinical practice. Discover how the University of Michigan leads groundbreaking clinical trials and refines care standards for complex GU cases.
Key Learning Outcomes:
- Understand and apply the latest diagnostic modalities for the classification and risk-stratification of genitourinary cancers.
- Appreciate the rapidly evolving therapeutic landscape, including the use of targeted agents, immunomodulators, and antibody-drug conjugates (ADCs).
- Identify impactful research findings that drive future diagnostic and prognostic strategies.
- Navigate clinical nuances in managing “in-between” cases, such as localized prostate cancer with nodal PSMA avidity.
- Evaluate the role of circulating tumor DNA (ctDNA) in risk-stratifying patients with Muscle-Invasive Bladder Cancer
Reviews
There are no reviews yet.